Bo Angelin
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 4
- Endocrine and Autonomic Systems top 10%
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 9
- Cholesterol and Lipid Metabolism 5
- Physiology top 10%
-
- Drug Transport and Resistance Mechanisms 3
-
- Adipokines, Inflammation, and Metabolic Diseases 2
-
- Peroxisome Proliferator-Activated Receptors 2
-
- Lipid metabolism and biosynthesis 2
- Co-authors
- P. PariniMats RudlingLars BerglundKurt EinarssonBihu GaoRenhai CaoBarbara CannonEbba Bråkenhielm
- Partner nations
- SwedenUnited States
In The Last Decade
Bo Angelin
17 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 434
- Cancer Research 223
- Endocrine and Autonomic Systems 98
- Surgery 630
- Physiology 252
Countries citing papers authored by Bo Angelin
This map shows the geographic impact of Bo Angelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Angelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Angelin more than expected).
Fields of papers citing papers by Bo Angelin
This network shows the impact of papers produced by Bo Angelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Angelin. The network helps show where Bo Angelin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Angelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 39 | |
| 2 | 2015 | 4 | |
| 3 | 2010 | 5 | |
| 4 | 2010 | 235 | |
| 5 | 2008 | 20 | |
| 6 | 2008 | 66 | |
| 7 | 2004 | 244 | |
| 8 | 2002 | 147 | |
| 9 | 2000 | 272 | |
| 10 | 1999 | 23 | |
| 11 | 1991 | 10 | |
| 12 | 1990 | 249 | |
| 13 | 1989 | 5 | |
| 14 | 1989 | 67 | |
| 15 | 1986 | 7 | |
| 16 | 1984 | 8 | |
| 17 | Effects of treatment with chenodeoxycholic acid on liver microsomal metabolism of steroids in man. | 1980 | 13 |
About Bo Angelin
Bo Angelin is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Surgery, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (9 papers), Cholesterol and Lipid Metabolism (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Cancer, Lipids, and Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (434 citations), Cancer Research (223 citations) and Endocrine and Autonomic Systems (98 citations). Bo Angelin has collaborated with scholars based in Sweden and United States. Frequent co-authors include P. Parini, Mats Rudling, Lars Berglund, Kurt Einarsson, Bihu Gao, Renhai Cao, Barbara Cannon, Ebba Bråkenhielm, Yihai Cao and Ingemar Björkhem. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.